Blog – Page 6 – Clinical Trial Results

Dr. Fatima Rodriguez and Dr. C. Michael Gibson discuss: A Proposed Stepwise Approach to Evaluation, Treatment and Tracking of Coronary Atherosclerosis

November 20, 2025

Sponsored by Cleerly, Women as One and International Atherosclerosis Society

Dr. Navar and Dr. C. Michael Gibson discuss the CORAL Reef Study: A new novel, oral PCSK9 inhibitor significantly reduces LDL-C.

November 19, 2025

Disclosures: TBD

Dr. Sandesh Dev and Dr. C. Michael Gibson discuss: Geographic Disparities in Transthyretin Amyloid Cardiomyopathy Prevalence in United States Veterans.

November 18, 2025

Disclosures: Supported by an independent educational grant from BridgeBio Pharma Inc.

Dr. Jim Januzzi and Dr. C. Michael Gibson discuss: Acoramidis Lowers NT-proBNP in a Larger Proportion of ATTRibute-CM Study Participants With Transthyretin Amyloid.

November 17, 2025

Disclosures: Supported by an independent educational grant from BridgeBio Pharma Inc.

Dr. Shamir Mehta and Dr. C. Michael Gibson discuss the findings of IPD meta-analysis from Complete Revascularization Trialists’ Collaboration: Does complete revasc reduce CV death or new MI compared to culprit-only PCI when considering the totality of RCT data?

November 13, 2025

Disclosures: TBD

Dr. Stephen Nicholls and Dr. C. Michael Gibson Discuss: SURPASS-CVOT — Once-weekly Tirzepatide versus Dulaglutide for Heart Failure Outcomes in Patients with Type 2 Diabetes, ASCVD, and History of Heart Failure (pre-specified analysis of the SURPASS-CVOT Randomized Clinical Trial)

November 10, 2025

Disclosures: TBD

Dr. Ambarish Pandey and Dr. C. Michael Gibson Discuss: FOOD-HF- Examining the Impact of Medically Tailored Meals vs Produce Supplements Delivered Conditionally vs Unconditionally in Heart Failure Readmissions and Emergency Department Visits: A Randomized Clinical Trial

November 10, 2025

Disclosures: TBD

Dr. William F Fearon and Dr. C. Michael Gibson Discuss: CAVIAR- Cardiac Allograft Vasculopathy Inhibition with AliRocumab: The CAVIAR Trial

November 10, 2025

Disclosures: TBD

Dr. Ambarish Pandey and Dr. C. Michael Gibson Discuss: POLY-HF – A Polypill Strategy for Heart Failure with Reduced Ejection Fraction: The POLY-HF Trial

November 10, 2025

Disclosures: TBD

Dr. Colin Berry and Dr. C. Michael Gibson Discuss: CorCMR – Non-Invasive Endotyping in Patients with Angina and No Obstructive Coronary Artery Disease: A Randomized, Controlled Trial

November 10, 2025

Disclosures: TBD